ULTRACEF Drug Patent Profile
✉ Email this page to a colleague
When do Ultracef patents expire, and when can generic versions of Ultracef launch?
Ultracef is a drug marketed by Bristol and Apothecon and is included in four NDAs.
The generic ingredient in ULTRACEF is cefadroxil/cefadroxil hemihydrate. Nineteen suppliers are listed for this compound. Additional details are available on the cefadroxil/cefadroxil hemihydrate profile page.
Summary for ULTRACEF
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Patent Applications: | 6,212 |
DailyMed Link: | ULTRACEF at DailyMed |